Literature DB >> 1438133

High osmotic pressure for Pneumocystis carinii London Resin White embedding enables fine immunocytochemistry studies: I. Golgi complex and cell-wall synthesis.

F Palluault1, B Soulez, C Slomianny, E Dei-Cas, J Y Cesbron, D Camus.   

Abstract

A method for embedding Pneumocystis carinii in hydrophilic resin (London Resin White) has been developed for immunocytochemistry studies. Using high osmotic pressure (about 850 mosmol) from fixation to embedding, this method improved the preservation of the fine structure as well as the antigenicity of rabbit- and SCID mouse-derived P. carinii. Cytochemistry studies were performed using colloidal gold-conjugated lectins (concanavalin A, glycine max, Ulex europaeus) that reacted with the cytoplasmic components (endoplasmic reticulum, Golgi vesicles). Colloidal gold-conjugated streptavidin was also tested and was found to be reactive with the parasite cell wall and cytoplasmic components, which precludes its indiscriminate use in P. carinii immunocytochemistry studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1438133     DOI: 10.1007/bf00931568

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  16 in total

1.  Streptavidin contains an RYD sequence which mimics the RGD receptor domain of fibronectin.

Authors:  R Alon; E A Bayer; M Wilchek
Journal:  Biochem Biophys Res Commun       Date:  1990-08-16       Impact factor: 3.575

2.  Ultrastructural localization of epitopes recognized by monoclonal antibodies produced to rat Pneumocystis carinii.

Authors:  H Yoshikawa; L E Debault; D C Graves
Journal:  J Protozool       Date:  1991 Nov-Dec

3.  The young rabbit: a nonimmunosuppressed model for Pneumocystis carinii pneumonia.

Authors:  B Soulez; E Dei-Cas; P Charet; G Mougeot; M Caillaux; D Camus
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

4.  Structural origins of high-affinity biotin binding to streptavidin.

Authors:  P C Weber; D H Ohlendorf; J J Wendoloski; F R Salemme
Journal:  Science       Date:  1989-01-06       Impact factor: 47.728

5.  Golgi complex and lysosomes in rabbit derived Pneumocystis carinii.

Authors:  F Palluault; E Dei-Cas; C Slomianny; B Soulez; D Camus
Journal:  Biol Cell       Date:  1990       Impact factor: 4.458

6.  Contrasting of Lowicryl K4M thin sections.

Authors:  J Roth; D J Taatjes; K T Tokuyasu
Journal:  Histochemistry       Date:  1990

7.  Glycoproteins of Pneumocystis carinii: characterization by electrophoresis and microscopy.

Authors:  E L Pesanti; J D Shanley
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

8.  Localization of host immunoglobulin G to the surface of Pneumocystis carinii.

Authors:  W Blumenfeld; R E Mandrell; G A Jarvis; J M Griffiss
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

9.  Pneumocystis carinii: surface reactive carbohydrates detected by lectin probes.

Authors:  M T Cushion; J A DeStefano; P D Walzer
Journal:  Exp Parasitol       Date:  1988-12       Impact factor: 2.011

10.  Introduction of Pneumocystis carinii in a colony of SCID mice.

Authors:  B Soulez; F Palluault; J Y Cesbron; E Dei-Cas; A Capron; D Camus
Journal:  J Protozool       Date:  1991 Nov-Dec
View more
  2 in total

Review 1.  Is Pneumocystis carinii a deep mycosis-like agent?

Authors:  E Dei-Cas; J C Cailliez; F Palluault; E M Aliouat; E Mazars; B Soulez; J Suppin; D Camus
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

2.  Cryptosporidium parvum-induced ileo-caecal adenocarcinoma and Wnt signaling in a mouse model.

Authors:  Sadia Benamrouz; Valerie Conseil; Magali Chabé; Marleen Praet; Christophe Audebert; Renaud Blervaque; Karine Guyot; Sophie Gazzola; Anthony Mouray; Thierry Chassat; Baptiste Delaire; Nathalie Goetinck; Nausicaa Gantois; Marwan Osman; Christian Slomianny; Vanessa Dehennaut; Tony Lefebvre; Eric Viscogliosi; Claude Cuvelier; Eduardo Dei-Cas; Colette Creusy; Gabriela Certad
Journal:  Dis Model Mech       Date:  2014-03-20       Impact factor: 5.758

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.